SCHEMBL4175212

SCHEMBL4175212

COc1ccc(/C=C(/C#N)S(=O)(=O)Cc2ccc(Cl)cc2Cl)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.44
▸ HTT P42858 2/20 0.44
▸ PKM P14618 2/20 0.44
▸ KDM4E B2RXH2 4/20 0.43
▸ EGFR P00533 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ HSD11B1 P28845 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ FLT1 P17948 1/20 0.40
▸ FLT4 P35916 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4175209 1.00 CYP1A2 (0.46) CYP1A2ALDH1A1HTTPKMKDM4E
SCHEMBL4175216 1.00 CYP1A2 (0.46) CYP1A2ALDH1A1HTTPKMKDM4E
SCHEMBL4183034 0.93 ALDH1A1 (0.48) CYP1A2ALDH1A1HTTPKMKDM4E
SCHEMBL4183029 0.93 ALDH1A1 (0.48) CYP1A2ALDH1A1HTTPKMKDM4E
SCHEMBL4183039 0.93 ALDH1A1 (0.48) CYP1A2ALDH1A1HTTPKMKDM4E
SCHEMBL4179381 0.89 EGFR (0.45) ALDH1A1KDM4EEGFRMAPTLMNA
SCHEMBL4179383 0.89 EGFR (0.45) ALDH1A1KDM4EEGFRMAPTLMNA
SCHEMBL4179379 0.89 EGFR (0.45) ALDH1A1KDM4EEGFRMAPTLMNA
SCHEMBL4182751 0.87 HPGD (0.49) CYP1A2ALDH1A1HTTPKMKDM4E
SCHEMBL4182756 0.87 HPGD (0.49) CYP1A2ALDH1A1HTTPKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 CYP1A2 1062/4885ALDH1A1 249/4885HTT 1825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback